Page 1 of Clinical Trials for "Urogenital Neoplasms", 4945 Total Matches
- 1RecruitingLast Updated: May 1, 2012Condition(s): Anus Neoplasms; Rectal Neoplasms; Urogenital Neoplasms
- 2Active, not recruitingLast Updated: May 25, 2010Condition(s): Prostatic Diseases; Genital Neoplasms, Male; Urogenital Neoplasms; Genital Diseases, Male; Adenocarcinoma; Prostatic Neoplasms; Neoplasms, Glandular and Epithelial; Carcinoma
- 3CompletedLast Updated: November 13, 2009Condition(s): Neoplasms; Neoplasms by Site; Urogenital Neoplasms; Genital Neoplasms, Female; Uterine Neoplasms; Endometrial Neoplasms; Cancer of Endometrium; Endometrial Cancer; Cancer of the Endometrium; Endometrium Cancer; Neoplasms, Endometrial
- 4Active, not recruitingLast Updated: August 23, 2011Condition(s): Gastrointestinal Neoplasms; Urogenital Neoplasms
- 5CompletedPharmacokinetic Study on the Administration of Nadroparin Dosing Serum HGF in Gynecological PatientsLast Updated: January 30, 2012Condition(s): Genital Diseases, Female; Ovarian Neoplasms; Urogenital Neoplasms
- 6CompletedLast Updated: March 2, 2007Condition(s): Carcinoma, Renal Cell; Urogenital Neoplasms; Urologic Neoplasms; Kidney Neoplasms
- 7AvailableLast Updated: May 24, 2012Condition(s): Prostate Neoplasms; Genital Neoplasms, Male; Urogenital Neoplasms; Genital Diseases, Male
- 8CompletedPhase 2 Study of ET-743 (Trabectedin) in Patients With Persistent or Recurrent Endometrial CarcinomaLast Updated: April 26, 2011Condition(s): Endometrial Neoplasms; Uterine Neoplasms; Genital Neoplasms, Female Urogenital Neoplasms
- 9CompletedLast Updated: March 15, 2011Condition(s): Prostatic Neoplasms,; Genital Neoplasms, Male,; Neoplasms,; Urogenital Neoplasms,; Genital Diseases, Male,; Prostatic Diseases,; Antineoplastic Agents,; Imatinib
- 10TerminatedLast Updated: February 14, 2012Condition(s): Carcinoma in Situ; Transitional Cell Carcinoma; Non-muscle Invasive Bladder Cancer
- 11CompletedLast Updated: May 7, 2012Condition(s): Carcinoma; Carcinoma, Renal Cell; Neuroendocrine Tumors; Carcinoid Tumor; Pancreatic Islet Cell Tumors
- 12CompletedLast Updated: April 24, 2012Condition(s): Non-Small Cell Lung Carcinoma; Breast Cancer; Melanoma; Upper GI Tract Carcinoma; Colon Carcinoma; Renal Cell Carcinoma; Bladder Carcinoma; Prostate Cancer
- 13Not yet recruitingLast Updated: September 27, 2011Condition(s): Renal Cell Carcinoma
- 14RecruitingLast Updated: November 23, 2011Condition(s): Carcinoma; Carcinoma Renal Cell; Kidney Neoplasms; Kidney Diseases; Chemokines
- 15RecruitingLast Updated: March 21, 2012Condition(s): Ovarian Cancer; Endometrial Cancer; Uterine Cervical Cancer
- 16RecruitingLast Updated: May 3, 2012Condition(s): Prostatic Neoplasm; Prostate Cancer; Prostatic Adenocarcinoma
- 17RecruitingLast Updated: May 17, 2012Condition(s): Bladder Neoplasm; Intravesical Drug Administration; Neoplasm Recurrence, Local; Transitional Cell, Carcinoma; Carcinoma in Situ; Mycobacterium
- 18TerminatedLast Updated: October 7, 2011Condition(s): Bladder Cancer
- 19CompletedLast Updated: November 3, 2010Condition(s): Renal Cell Carcinoma
- 20Active, not recruitingLast Updated: January 2, 2012Condition(s): Prostate Cancer
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?cond=%22Urogenital+Neoplasms%22
